Vitiligo and quality of life: the dark face of whiteness.
作者信息
Ezzedine K, Eleftheriadou V
机构信息
Department of Dermatology, Henri Mondor Hospital and EpiDermE, Université Paris-Est, Créteil Val-de-Marne, 94010, Créteil, France.
Centre of Evidence Based Dermatology, University of Nottingham, Nottingham, U.K.
出版信息
Br J Dermatol. 2018 Jan;178(1):28-29. doi: 10.1111/bjd.16072.
PMID:29357599
Abstract
摘要
相似文献
1
Vitiligo and quality of life: the dark face of whiteness.
Br J Dermatol. 2018 Jan;178(1):28-29. doi: 10.1111/bjd.16072.
2
Transcultural assessment of quality of life in patients with vitiligo.
J Am Acad Dermatol. 2022 May;86(5):1114-1116. doi: 10.1016/j.jaad.2021.03.118. Epub 2021 Apr 20.
3
Vitiligo Impact Scale (VIS)-22: A measure of the psycho-social burden of vitiligo.
Indian J Dermatol Venereol Leprol. 2022 Sep-Oct;88(5):691-695. doi: 10.25259/IJDVL_637_2021.
4
The long road to valid outcomes in vitiligo.
Br J Dermatol. 2019 Mar;180(3):454-455. doi: 10.1111/bjd.17409.
5
Measuring the Impact of Vitiligo: Behind the White Spots.
J Invest Dermatol. 2016 Jan;136(1):6-7. doi: 10.1038/JID.2015.407.
6
Social Anxiety and Quality of Life in Vitiligo and Acne Patients with Facial Involvement: A Cross-Sectional Controlled Study.
Am J Clin Dermatol. 2016 Jun;17(3):305-11. doi: 10.1007/s40257-016-0172-x.
7
Health-related quality of life in paediatric patients with vitiligo: a systematic review and meta-analysis.
J Eur Acad Dermatol Venereol. 2021 Nov;35(11):e755-e756. doi: 10.1111/jdv.17382. Epub 2021 Jul 23.
8
Impact of nonsegmental vitiligo on patients' health-related quality of life in the United States.
Br J Dermatol. 2022 Oct;187(4):603-606. doi: 10.1111/bjd.21672. Epub 2022 Jun 29.
9
The Vitiligo Impact Patient Scale (VIPs): Development and Validation of a Vitiligo Burden Assessment Tool.
J Invest Dermatol. 2016 Jan;136(1):52-8. doi: 10.1038/JID.2015.398.
10
Effect of Cosmetic Camouflage in Adults With Vitiligo.
Actas Dermosifiliogr. 2022 Mar;113(3):316-318. doi: 10.1016/j.ad.2020.04.018. Epub 2021 Sep 13.
引用本文的文献
1
[Quality of life, disease burden and healthcare need of patients with vitiligo].
Dermatologie (Heidelb). 2024 May;75(5):404-411. doi: 10.1007/s00105-024-05312-z. Epub 2024 Mar 11.
2
Oral gliadin-protected superoxide dismutase in addition to phototherapy for treating non-segmental vitiligo: A 24-week prospective randomized placebo-controlled study.
J Eur Acad Dermatol Venereol. 2021 Aug;35(8):1725-1729. doi: 10.1111/jdv.17331. Epub 2021 May 13.
3
Changes in sICAM-1 and GM-CSF levels in skin tissue fluid and expression of IL-6, IL-17 and TNF-α in blood of patients with vitiligo.
Exp Ther Med. 2019 Jan;17(1):408-412. doi: 10.3892/etm.2018.6937. Epub 2018 Nov 7.
Zotero 插件